Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo

Abstract

Abstract-We have previously shown that long-term treatment with an inflammatory cytokine from the adventitia causes the development of coronary vascular lesions, with the accumulation of macrophages. Recent studies in vitro have suggested that small G-protein Rho and its effector, Rho-kinase/ROK/ROCK, may be the key molecules for various cellular functions, including cell adhesion and movement. In this study, we examined whether adventitia-derived macrophages cause the formation of coronary vascular lesions in vivo and, if so, whether Rho-kinase is involved in the process. Porcine coronary segments from the adventitia were chronically treated with monocyte chemoattractant protein-1 alone, oxidized low density lipoprotein alone, or both. Vascular lesion formation (neointimal formation and development of vascular remodeling) was mostly enhanced at the coronary segment cotreated with monocyte chemoattractant protein-1 and oxidized low density lipoprotein, where the phosphorylation of myosin binding subunit of myosin phosphatase was increased, indicating an increased activity of Rho-kinase in vivo. Histological examination demonstrated that macrophages were accumulated at the adventitia and thereafter migrated into the vascular wall. Long-term oral treatment with fasudil, which is metabolized to a specific Rho-kinase inhibitor (hydroxyfasudil) after oral absorption, markedly inhibited the myosin binding subunit phosphorylation, the macrophage accumulation and migration, and the coronary lesion formation in vivo. These results indicate that Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in our porcine model in vivo. (Arterioscler Thromb Vasc

Increased Epicardial Adipose Tissue Thickness Is Correlated with Ascending Aortic Diameter

“…In our opinion, increased fat accumulation may have a critical role in this entity. Bioactive molecules from periaortic tissues may alter arterial homeostasis (Shimokawa et al 1996;Miyata et al 2000). Perivascular adipose tissue also releases factors that might profoundly modulate vascular function (Löhn et al 2002).…”

Inhibiting nonmuscle myosin II impedes inflammatory infiltration and ameliorates progressive renal disease

“…12 Blebbistatin was recently found to mitigate the migration of a variety of immune competent cells, [13][14][15][16][17][18] suggesting that NMII is crucial for immunocyte motility. Consistently, a growing body of evidence reveals that indirect inactivation of NMII through inhibition of myosin light chain kinase 19,20 or Rho kinase 18,[21][22][23][24] impaired leukocyte migration and improved inflammation. Nevertheless, the exact role of NMII in mediating leukocytes' inflammatory response remains uncertain.…”

Nitric Oxide: Considerations for the Treatment of Ischemic Stroke

“…Rho kinase (ROCK) is a serine-threonine kinase whose activity is modulated by isoprenoid intermediate geranygeranylpyrophosphate (GGPP). Rho kinase is implicated in the pathophysiology of atherosclerosis (Miyata et al, 2000), myocardial infarction, and hypertension (Uehata et al, 1997). Activation of Rho kinase in endothelial cells under hypoxic conditions (Wolfrum et al, 2004) has been related to the mechanism responsible for the downregulation of eNOS during and after ischemia (Takemoto et al, 2002;Ming et al, 2002;Wolfrum et al, 2004;Jin et al, 2006).…”